Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

203

HTML

1603

Tables (1-2)

151

Sum=1957

Aug 1, 2004 (publication date) through Jul 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 1, 2004; 10(15): 2281-2283
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2281

Table 1 Demographic and clinical variables of 23 patients with BTI

	Benign conditions	Malignant conditions
No (%)	10/23(43.5)	13/23(56.5)
Average duration of treatment (d)	7 ± 1	10 ± 1
Underlying condition (No.)	Choledocholitiasis (7)	Cholangiocarcinoma (6)
	Acute cholecystitis (2)	Pancreatic carcinoma (4)
	Iatrogenic stenosis (1)	Gallbladder carcinoma (2)
		Infiltrating hepatoma (1)
Previous instrumental invasive maneuvers (No)	None (5)	None (3)
	PTD (3)	PTD (10)
	ERCP (2)

Abbreviations: BTI = biliary tract infections; ERCP = endoscopic retrograde cholangio-pancreatography; PTD = percutaneous transhepatic drainage.

Citation: Bassotti G, Chistolini F, Sietchiping-Nzepa F, Roberto G, Morelli A. Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections. World J Gastroenterol 2004; 10(15): 2281-2283
URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2281.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2281